Autologous CTL response against cancer stem‐like cells/cancer‐initiating cells of bone malignant fibrous histiocytoma

scientific article published on May 31, 2011

Autologous CTL response against cancer stem‐like cells/cancer‐initiating cells of bone malignant fibrous histiocytoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1349-7006.2011.01962.X
P953full work available online athttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.2011.01962.x
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.2011.01962.x
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2011.01962.x
P698PubMed publication ID21518139
P5875ResearchGate publication ID51075119

P50authorMasanobu KanoQ87897587
Tomohide TsukaharaQ88499669
Makoto EmoriQ89868598
Toshihiko TorigoeQ91737677
Noriyuki SatōQ113953738
Toshihiko YamashitaQ114018411
Satoshi KawaguchiQ114426896
Masaki MuraseQ114426928
Takuro WadaQ59200291
P2093author name stringNoriyuki Sato
P2860cites workStrategies of tumor immune evasionQ22305820
Stem cells, cancer, and cancer stem cellsQ27860878
Cancer stem cells in solid tumours: accumulating evidence and unresolved questionsQ28293535
Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesisQ37186425
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growthQ39703155
Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomasQ39787753
Natural killer cells kill human melanoma cells with characteristics of cancer stem cellsQ39843692
HLA-restricted specific tumor cytolysis by autologous T-lymphocytes infiltrating metastatic bone malignant fibrous histiocytoma of lymph nodeQ40328211
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cellsQ42148487
Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 casesQ44459385
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.Q46004947
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomasQ48381036
Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup studyQ73042273
Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology SocietyQ73199725
Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5Q80331639
Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumorsQ83603523
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)1443-1447
P577publication date2011-05-31
P1433published inCancer ScienceQ326125
P1476titleAutologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma
Autologous CTL response against cancer stem‐like cells/cancer‐initiating cells of bone malignant fibrous histiocytoma
P478volume102

Reverse relations

cites work (P2860)
Q38502913An inhibitor of K+ channels modulates human endometrial tumor-initiating cells.
Q88647698Cancer stem cells: Regulation programs, immunological properties and immunotherapy
Q26781794Immune responses to human cancer stem-like cells/cancer-initiating cells
Q27014031Immunotargeting of cancer stem cells
Q34196481Immunotherapeutic Intervention against Sarcomas
Q90640291Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells
Q36585140Monitoring cancer stem cells: insights into clinical oncology
Q39099804Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.
Q38902336Peptide vaccination therapy: Towards the next generation
Q36754981Primary malignant fibrous histiocytoma of the breast: report of one case.
Q55504567Researche advances on CIK cells and their clinical use in lung cancer
Q38829558The future of immunotherapy for sarcoma

Search more.